{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T05:10:36Z","timestamp":1682831436535},"reference-count":33,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.vaccine.2004.09.034","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T17:07:01Z","timestamp":1100192821000},"page":"1730-1738","source":"Crossref","is-referenced-by-count":2,"title":["Programming of CTL with heat-killed Brucella abortus and antigen allows soluble antigen alone to generate effective secondary CTL"],"prefix":"10.1016","volume":"23","author":[{"given":"Satoshi","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basil","family":"Golding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.09.034_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev.immunol.16.1.201","article-title":"T cell memory","volume":"16","author":"Dutton","year":"1998","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2004.09.034_bib2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0167-5699(98)01301-2","article-title":"Cross-presentation: a general mechanism for CTL response and tolerance","volume":"19","author":"Carbone","year":"1998","journal-title":"Immunol Today"},{"issue":"6","key":"10.1016\/j.vaccine.2004.09.034_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1046\/j.1440-1711.1999.00876.x","article-title":"Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulation","volume":"77","author":"Robinson","year":"1999","journal-title":"Immunol Cell Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2004.09.034_bib4","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.4049\/jimmunol.155.12.5728","article-title":"Involvement of natural killer cells in nitric oxide production by spleen cells after stimulation with Mycobacterium bovis BCG. Study of the mechanism of the different abilities of viable and killed BCG","volume":"155","author":"Yang","year":"1995","journal-title":"J Immunol"},{"issue":"5547","key":"10.1016\/j.vaccine.2004.09.034_bib5","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.1064571","article-title":"Priming of memory but not effector CD8 T cells by a killed bacterial vaccine","volume":"294","author":"Lauvau","year":"2001","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2004.09.034_bib6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4049\/jimmunol.161.3.1447","article-title":"Control of IL-12 and IFN-production in response to live or dead bacteria by TNF and other factors","volume":"161","author":"Zhan","year":"1998","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.09.034_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.183.1.283","article-title":"Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity","volume":"183","author":"Celluzzi","year":"1996","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2004.09.034_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/jimmunol.150.2.438","article-title":"Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules","volume":"150","author":"Rock","year":"1993","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.09.034_bib9","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V90.4.1594","article-title":"Presentation of exogenous protein antigens on major hitocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines","volume":"90","author":"Brossart","year":"1997","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.vaccine.2004.09.034_bib10","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.1073\/pnas.89.17.8308","article-title":"Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo","volume":"89","author":"Raychaudhuri","year":"1992","journal-title":"Proc Nathl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2004.09.034_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.immunol.19.1.47","article-title":"Cross-presentation, dendritic cells, tolerance and immunity","volume":"19","author":"Heath","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2004.09.034_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/75365","article-title":"Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism","volume":"18","author":"Cho","year":"2000","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.09.034_bib13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4049\/jimmunol.167.3.1423","article-title":"IL-12 induction by a Th1-inducing adjuvant in vivo: dendritic cell subsets and regulation by IL-10","volume":"167","author":"Huang","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.09.034_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4049\/jimmunol.159.1.107","article-title":"Inhibition of primary and recall allergen-specific T helper cell type 2-mediated responses by a T helper cell type 1 stimulus","volume":"159","author":"Scott","year":"1997","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2004.09.034_bib15","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1128\/JVI.70.5.3084-3092.1996","article-title":"Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB\/c mice","volume":"70","author":"Lapham","year":"1996","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2004.09.034_bib16","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1128\/JVI.69.6.3299-3307.1995","article-title":"Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type I induces neutralizing anti-HIV antibodies, and the V3-B abortus conjugate is effective even after CD4+ T-cell depletion","volume":"69","author":"Golding","year":"1995","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2004.09.034_bib17","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/sj.gt.3301353","article-title":"Enhancement of anti-tumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines","volume":"7","author":"Akiyama","year":"2000","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2004.09.034_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0022-1759(94)90236-4","article-title":"Determination of lymphocyte division by flow cytometry","volume":"171","author":"Lyons","year":"1994","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2004.09.034_bib19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4049\/jimmunol.168.2.834","article-title":"Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1","volume":"168","author":"Coles","year":"2002","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2004.09.034_bib20","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.4049\/jimmunol.165.11.6123","article-title":"In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes","volume":"165","author":"Nelson","year":"2000","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2004.09.034_bib21","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.4049\/jimmunol.161.10.5338","article-title":"Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division","volume":"161","author":"Oehen","year":"1998","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.09.034_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"6684","key":"10.1016\/j.vaccine.2004.09.034_bib23","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/30989","article-title":"A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"issue":"6684","key":"10.1016\/j.vaccine.2004.09.034_bib24","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/30996","article-title":"Help for cytotoxic-T-cell responses is mediated by CD40 signalling","volume":"393","author":"Bennett","year":"1998","journal-title":"Nature"},{"issue":"6684","key":"10.1016\/j.vaccine.2004.09.034_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/31002","article-title":"T-cell help for cytotoxic T lymphocytes is mediated by CD40\u2013CD40L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2004.09.034_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ni912","article-title":"Dynamic programming of CD8+ T lymphocyte responses","volume":"4","author":"van Stipdonk","year":"2003","journal-title":"Nat Immunol"},{"issue":"6925","key":"10.1016\/j.vaccine.2004.09.034_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4+ T cells are required for secondary expansion and memory CD8+ T lymphocytes","volume":"421","author":"Janssen","year":"2003","journal-title":"Nature"},{"issue":"5617","key":"10.1016\/j.vaccine.2004.09.034_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1082305","article-title":"Requirement for CD4 T cell help in generating functional CD8 T cell memory","volume":"300","author":"Shedlock","year":"2003","journal-title":"Science"},{"issue":"5617","key":"10.1016\/j.vaccine.2004.09.034_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.1083317","article-title":"Defective CD8 T cell memory following acute infection without CD4 T cell help","volume":"300","author":"Sun","year":"2003","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.vaccine.2004.09.034_bib30","first-page":"3340","article-title":"Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration","volume":"59","author":"Eggert","year":"1999","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.vaccine.2004.09.034_bib31","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.gt.3301160","article-title":"Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity","volume":"7","author":"Wang","year":"2000","journal-title":"Gene Ther"},{"issue":"12","key":"10.1016\/j.vaccine.2004.09.034_bib32","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.4049\/jimmunol.171.12.6339","article-title":"CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo","volume":"171","author":"Wang","year":"2003","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2004.09.034_bib33","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.4049\/jimmunol.171.11.5727","article-title":"IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion","volume":"171","author":"D'Souza","year":"2003","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04007443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04007443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T04:48:38Z","timestamp":1682830118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04007443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":33,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0264410X04007443"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.09.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}